Literature DB >> 19246023

Reflections on the white plague.

Alimuddin Zumla1, Peter Mwaba, Jim Huggett, Nathan Kapata, Duncan Chanda, John Grange.   

Abstract

Tuberculosis continues to be one of the leading causes of morbidity and mortality from infectious disease worldwide. When WHO declared tuberculosis a global emergency in 1993, the initial response from the international community was sluggish and inadequate. A resurgence of the disease, the emergence of multidrug-resistant and extensively drug-resistant strains, and the detrimental effect of the concurrent tuberculosis and HIV/AIDS epidemics on national control programmes in sub-Saharan Africa have all occurred despite the availability of effective combination treatment regimens. On the positive side, funding agencies and donor governments are at long last taking a serious interest in investing in tuberculosis research priorities defined by the Stop TB Partnership. Although this investment introduces optimism for eventual control of the White Plague, past failures remind us not to be complacent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19246023     DOI: 10.1016/S1473-3099(09)70045-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  10 in total

1.  Prognostic value of initial echocardiographic features in patients with tuberculous pericarditis.

Authors:  Hyung Oh Choi; Jong-Min Song; Tae Sun Shim; Sang-Hyun Kim; In-Hyun Jung; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Korean Circ J       Date:  2010-08-31       Impact factor: 3.243

Review 2.  Global epidemiology of tuberculosis.

Authors:  Philippe Glaziou; Charalambos Sismanidis; Katherine Floyd; Mario Raviglione
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-30       Impact factor: 6.915

3.  HIV-Associated Tuberculosis.

Authors:  Kogieleum Naidoo; Kasavan Naidoo; Nesri Padayatchi; Quarraisha Abdool Karim
Journal:  Clin Dev Immunol       Date:  2010-09-13

4.  Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral centre.

Authors:  Daniel J B Marks; Marie D Fisk; Chieh Y Koo; Menelaos Pavlou; Lorraine Peck; Simon F Lee; David Lawrence; M Bruce Macrae; A Peter R Wilson; Jeremy S Brown; Robert F Miller; Alimuddin I Zumla
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

5.  Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.

Authors:  Ana Luisa de Jesus Lopes Ribeiro; Giulia Degiacomi; Fanny Ewann; Silvia Buroni; Maria Loreto Incandela; Laurent R Chiarelli; Giorgia Mori; Jaeseung Kim; Monica Contreras-Dominguez; Young-Sam Park; Sung-Jun Han; Priscille Brodin; Giovanna Valentini; Menico Rizzi; Giovanna Riccardi; Maria Rosalia Pasca
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

Review 6.  Tuberculosis: epidemiology and control.

Authors:  Giorgia Sulis; Alberto Roggi; Alberto Matteelli; Mario C Raviglione
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

Review 7.  Recent developments in the diagnosis and management of tuberculosis.

Authors:  Giorgia Sulis; Rosella Centis; Giovanni Sotgiu; Lia D'Ambrosio; Emanuele Pontali; Antonio Spanevello; Alberto Matteelli; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-03       Impact factor: 2.871

8.  Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.

Authors:  Francine Ntoumi; Pontiano Kaleebu; Eusebio Macete; Sayoki Mfinanga; Jeremiah Chakaya; Dorothy Yeboah-Manu; Matthew Bates; Peter Mwaba; Markus Maeurer; Eskild Petersen; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2016-03-08       Impact factor: 3.623

9.  Predictors and Clinical Outcomes in Empyema Thoracis Patients Presenting to the Emergency Department Undergoing Video-Assisted Thoracoscopic Surgery.

Authors:  Yuan-Ming Tsai; Nikita Gamper; Tsai-Wang Huang; Shih-Chun Lee; And Hung Chang
Journal:  J Clin Med       Date:  2019-10-03       Impact factor: 4.241

Review 10.  Rifampicin Mono-Resistant Tuberculosis-A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control.

Authors:  Jason H Malenfant; Timothy F Brewer
Journal:  Open Forum Infect Dis       Date:  2021-01-28       Impact factor: 3.835

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.